CHICAGO — Vaccination of boys and men against the human papillomavirus reduces their risk of head and neck cancers and other malignancies, a new analysis shows, adding to the vaccine's proven ...
Share on Pinterest New research shows HPV vaccinations may reduce the risk of HPV-related cancers by as much as 56% in males and 36% in females. Boston Globe/Getty Images A new analysis suggests ...
The vaccine was introduced in 2006 and originally marketed to women and girls. Nearly two decades after the launch of the first HPV vaccine, mounting evidence shows that people who got vaccinated ...
WASHINGTON — New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States. The HPV vaccine was ...
HPV vaccination has long been linked to reduced cervical cancers in women. New research shows that the HPV vaccine dramatically reduces the risk of head and neck cancers, especially in boys and men.
Adolescent boys and men who get HPV vaccines have a significantly lower risk of developing head and neck cancers later in life, according to a long-term study out of Thomas Jefferson University.
Experts said the HPV vaccine should not just be seen as a jab to prevent cervical cancer as it has major benefits for boys ...
The narrative around HPV vaccinations has typically centered on their ability to prevent cervical cancer in women. But a new ...
New research suggests the human papillomavirus vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States. The HPV vaccine was ...
The vaccine prevents infection of several HPV subtypes, including HPV-16 and HPV-18, which causes 70% of cervical cancer as well as other cancers in the genital area, and more rarely, in the ...
By far, the best way to prevent HPV transmission (apart from never having close contact with anyone) is vaccination. The HPV ...
Nearly two decades after the launch of the first HPV vaccine, mounting evidence shows that people who got vaccinated are dramatically less likely to develop HPV-related cancers in adulthood.